Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
暂无分享,去创建一个
Christopher I Amos | G. Hortobagyi | C. Amos | V. Valero | A. González-Angulo | B. Arun | C. Albarracin | Adriana López | Ana Maria Gonzalez-Angulo | Vicente Valero | Gabriel N Hortobagyi | Banu K Arun | Constance T Albarracin | Deann P Atchley | Adriana Lopez | Chris Amos | Deann P. D. Atchley | D. Atchley
[1] Z. Shao,et al. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified , 2008, Breast Cancer Research and Treatment.
[2] J. Lubiński,et al. Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers , 2008, Breast Cancer Research and Treatment.
[3] S. Narod,et al. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.
[4] A. Musolino,et al. BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study. , 2007, Breast.
[5] J. Weidhaas,et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Amy V Kapp,et al. Discovery and validation of breast cancer subtypes , 2006, BMC Genomics.
[7] I. Siccama,et al. Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data , 2006, Journal of Clinical Pathology.
[8] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[9] B. Mukesh,et al. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] D. Crivellari,et al. Familial breast cancer: characteristics and outcome of BRCA 1–2 positive and negative cases , 2005, BMC Cancer.
[11] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[12] William D. Foulkes,et al. Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer , 2004 .
[13] L. Bégin,et al. The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer , 2004, Cancer Research.
[14] L. Bégin,et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. , 2004, Journal of the National Cancer Institute.
[15] D. Rimm,et al. BRCA Status, Molecular Markers, and Clinical Variables in Early, Conservatively Managed Breast Cancer , 2003, The breast journal.
[16] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[17] Y. Miki,et al. Clinicopathologic analysis of BRCA1‐ or BRCA2‐associated hereditary breast carcinoma in Japanese women , 1999, Cancer.
[18] Daniel Birnbaum,et al. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes , 1999, Cancer.
[19] L. Norton,et al. BRCA-associated breast cancer: absence of a characteristic immunophenotype. , 1998, Cancer research.
[20] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[21] J. Ranstam,et al. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M N Pollak,et al. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women , 1997, Cancer.
[23] Å. Borg,et al. Tumour biological features of BRCA1-induced breast and ovarian cancer. , 1997, European journal of cancer.
[24] G M Lenoir,et al. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage , 1996, Cancer.
[25] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.